Formulation and Drug Delivery

>

Latest News

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
AstraZeneca and Alteogen Sign License Agreement for Developing Subcutaneous Formulations of Oncology Assets

March 25th 2025

Under the agreement, AstraZeneca will use Alteogen’s proprietary hyaluronidase platform technology to develop and commercialize subcutaneous formulations of multiple oncology assets in its portfolio.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com
FDA Approves First Generics of Rivaroxaban Tablets

March 12th 2025

Magnified View of Lipid Nanoparticles | Image Credit: ©Aniwat - stock.adobe.com
Organic Nanoparticle-Based Drug-Delivery Systems as Alternatives to Lipid Nanoparticles

March 9th 2025

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
FDA Approves Evrysdi Tablet from Roche for Spinal Muscular Atrophy

February 17th 2025

Two dosing pens of a fictitious semaglutide drug (GLP-1) on a scale facing a dumbbell. Concept for alternative ways to loose weight. | Image Credit: © Andreas Prott - Stock.adobe.com
Next-Generation Anti-Obesity Medicines

February 8th 2025

Video Interviews
Podcasts

More News